Growing Antibody Industry in China Sees Major Opportunities
Yet, Challenges Remain as Companies Need More Talent and Resources to Market Globally
Supplement: CRISPR in the Courthouse
An Interview with Law Professor Jacob Sherkow
Supplement: CRISPR Enters the Clinic
Using CRISPR-Altered Cells to Fight Disease
The Scoop: CRISPR Patent Case Argued Before Appeals Court
Final Verdict Could Impact Future Research and Funding
For full access to this article login to GEN Select now.
NGS Systems Secure Place in Clinic
- Next-gen sequencing (NGS), the media-friendly moniker for automated massively parallel DNA or RNA sequencing technology, has made the leap from a powerhouse tool for molecular biology research and drug discovery and development to the clinical arena. Not an easy feat for a complex, expensive technology that generates huge ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.